Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2872 |  OVID Ovid Therapeutics Inc. - Common Stock | 2.71 USD | -3.21% | -3.90% | +15.32% | +146.36% | 529.26 M USD | ||
| 2883 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 10.81 USD | -1.10% | -5.18% | +8.21% | +159.86% | 528.50 M USD | ||
| 2889 |  CABA Cabaletta Bio, Inc. - Common Stock | 3.13 USD | 0.00% | +14.65% | +13.82% | +90.85% | 530.68 M USD | ||
| 2891 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 6.28 USD | -5.28% | +11.94% | +61.86% | +390.63% | 501.17 M USD | ||
| 2899 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.10 USD | -3.80% | -1.82% | +8.58% | +107.69% | 500.93 M USD | ||
| 2900 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 10.78 USD | -3.84% | -7.15% | -15.85% | -43.26% | 499.95 M USD | ||
| 2915 |  EVMN Evommune, Inc. Common Stock | 13.20 USD | -5.58% | -9.71% | +17.75% | -23.79% | 479.06 M USD | ||
| 2928 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.43 USD | -4.32% | -6.93% | -14.31% | +603.17% | 472.55 M USD | ||
| 2930 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.84 USD | -4.00% | -7.25% | +12.61% | +48.26% | 472.42 M USD | ||
| 2934 |  RZLT Rezolute, Inc. - Common Stock | 4.82 USD | -5.30% | +4.56% | -2.63% | -31.14% | 464.13 M USD | ||
| 2944 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.58 USD | -1.86% | +19.70% | +3.27% | -24.04% | 477.67 M USD | ||
| 2947 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.26 USD | -2.01% | +5.47% | +4.28% | +5.71% | 475.38 M USD | ||
| 2956 |  EDIT Editas Medicine, Inc. - Common Stock | 3.05 USD | -1.93% | +8.54% | +15.97% | +8.16% | 468.42 M USD | ||
| 2957 |  PBYI Puma Biotechnology Inc - Common Stock | 9.03 USD | -2.27% | +1.35% | +12.31% | +70.38% | 466.13 M USD | ||
| 2962 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 7.00 USD | -5.28% | +4.79% | -7.53% | -21.17% | 450.38 M USD | ||
| 2970 |  OCGN Ocugen, Inc. - Common Stock | 1.33 USD | -4.32% | -0.75% | +6.40% | +31.68% | 451.02 M USD | ||
| 2983 |  BNTC Benitec Biopharma Inc. - Common Stock | 13.46 USD | -0.15% | +7.51% | +16.03% | -18.96% | 462.41 M USD | ||
| 2991 |  EYPT EyePoint, Inc. - Common Stock | 5.11 USD | -3.95% | +21.96% | -59.05% | -57.42% | 440.54 M USD | ||
| 2999 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 12.91 USD | -2.57% | -3.73% | +2.79% | -12.18% | 441.10 M USD | ||
| 3024 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.30 USD | -2.39% | +3.11% | +11.11% | +65.11% | 425.08 M USD |
Haberler Biotechnology Stocks
Deutsche Bank, argenx hissesini değerleme nedeniyle Tut’a düşürdü
Monte Rosa Therapeutics hissesi neden düşüyor?
Biomea Fusion hisseleri diyabet çalışması kayıt tamamlanmasıyla yükseldi
Monte Rosa hisseleri faz 2 prostat kanseri çalışması başlarken düştü
H.C. Wainwright, Biomea Fusion hissesi için hedef fiyatı korudu
Crinetics Pharmaceuticals hissesi 84,8 dolarda zirve yaptı
FDA, Capricor’un deramiocel incelemesini 22 Kasım’a uzattı
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |